Iovance Biotherapeutics Inc (IOVA) stock news · rev $263.5M
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
This IOVA news page leads with what Iovance Biotherapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for IOVA yet. We will not pad this page with generic market recap.
Latest reported IOVA revenue for 2025-12-31 was $263.5M. Net income was -$391.0M. Revenue was up 60.6% from 2024-12-31 to 2025-12-31. IOVA currently screens at market cap $1.89B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IOVA stock page; for the tape open the quote page.
IOVA stock news FAQ
What are IOVA's latest revenue and net income?
Latest cached Iovance Biotherapeutics Inc (IOVA) revenue for Dec 31, 2025 was $263.5M. Net income was -$391.0M. Statements: https://lician.com/financials/iova
How did IOVA revenue change from the prior cached period?
Cached Iovance Biotherapeutics Inc (IOVA) revenue was up 60.6% from $164.1M (Dec 31, 2024) to $263.5M (Dec 31, 2025). Statements: https://lician.com/financials/iova
What is IOVA's market cap?
Iovance Biotherapeutics Inc (IOVA) market cap is $1.89B on the latest cached fundamentals snapshot.
What kind of company is IOVA?
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
Where is IOVA stock news listed?
Cached stock news for Iovance Biotherapeutics Inc (IOVA) is listed at https://lician.com/news/iova. Filings: https://lician.com/sec/iova
Not investment advice.